Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lot Quality Assurance Sampling | 8 | 2015 | 17 | 2.870 |
Why?
|
Disease Outbreaks | 13 | 2021 | 1758 | 1.510 |
Why?
|
Schistosoma mansoni | 3 | 2012 | 156 | 0.860 |
Why?
|
Schistosomiasis mansoni | 2 | 2012 | 94 | 0.790 |
Why?
|
Cluster Analysis | 8 | 2015 | 2698 | 0.690 |
Why?
|
Space-Time Clustering | 2 | 2009 | 46 | 0.650 |
Why?
|
Sentinel Surveillance | 3 | 2011 | 293 | 0.630 |
Why?
|
Quality Assurance, Health Care | 5 | 2015 | 2179 | 0.630 |
Why?
|
Program Evaluation | 5 | 2018 | 2487 | 0.620 |
Why?
|
Poliomyelitis | 2 | 2018 | 95 | 0.580 |
Why?
|
Population Surveillance | 6 | 2014 | 2609 | 0.580 |
Why?
|
Parasite Egg Count | 2 | 2012 | 29 | 0.540 |
Why?
|
Basic Reproduction Number | 2 | 2021 | 35 | 0.540 |
Why?
|
Influenza, Human | 4 | 2013 | 1533 | 0.530 |
Why?
|
Sampling Studies | 2 | 2015 | 613 | 0.530 |
Why?
|
Drug Resistance, Viral | 2 | 2013 | 857 | 0.490 |
Why?
|
Entropy | 1 | 2015 | 210 | 0.490 |
Why?
|
Bayes Theorem | 2 | 2013 | 2322 | 0.480 |
Why?
|
Data Interpretation, Statistical | 4 | 2013 | 2694 | 0.470 |
Why?
|
HIV-1 | 4 | 2015 | 6848 | 0.420 |
Why?
|
Mass Vaccination | 1 | 2014 | 109 | 0.410 |
Why?
|
Data Collection | 3 | 2014 | 3317 | 0.410 |
Why?
|
Tuberculosis, Pulmonary | 4 | 2016 | 832 | 0.390 |
Why?
|
Crime Victims | 1 | 2015 | 329 | 0.380 |
Why?
|
Health Surveys | 3 | 2015 | 4060 | 0.360 |
Why?
|
Computer Simulation | 9 | 2018 | 6195 | 0.340 |
Why?
|
Public Sector | 2 | 2012 | 265 | 0.340 |
Why?
|
Influenza A Virus, H1N1 Subtype | 2 | 2012 | 448 | 0.340 |
Why?
|
Biostatistics | 1 | 2011 | 163 | 0.330 |
Why?
|
HIV Infections | 6 | 2015 | 17128 | 0.330 |
Why?
|
Tuberculosis, Multidrug-Resistant | 5 | 2016 | 931 | 0.320 |
Why?
|
Immunization | 1 | 2013 | 1228 | 0.310 |
Why?
|
Epidemiologic Methods | 1 | 2013 | 1342 | 0.310 |
Why?
|
Topography, Medical | 1 | 2007 | 37 | 0.300 |
Why?
|
Firearms | 1 | 2015 | 625 | 0.300 |
Why?
|
Disease Transmission, Infectious | 1 | 2013 | 559 | 0.300 |
Why?
|
Leukemia | 2 | 2014 | 1511 | 0.290 |
Why?
|
Research Design | 2 | 2021 | 6168 | 0.280 |
Why?
|
Health Care Surveys | 1 | 2014 | 2433 | 0.270 |
Why?
|
Sample Size | 3 | 2015 | 839 | 0.260 |
Why?
|
Health Status Indicators | 1 | 2011 | 968 | 0.250 |
Why?
|
HIV | 1 | 2012 | 1579 | 0.250 |
Why?
|
Epidemiologic Measurements | 1 | 2004 | 22 | 0.240 |
Why?
|
Prevalence | 10 | 2022 | 15641 | 0.240 |
Why?
|
Models, Statistical | 6 | 2015 | 5066 | 0.240 |
Why?
|
Drug Resistance, Bacterial | 1 | 2010 | 1053 | 0.210 |
Why?
|
Decision Support Techniques | 1 | 2012 | 1999 | 0.200 |
Why?
|
Health Status | 1 | 2015 | 4079 | 0.200 |
Why?
|
Delivery of Health Care | 2 | 2018 | 5317 | 0.190 |
Why?
|
DNA, Viral | 1 | 2007 | 2195 | 0.170 |
Why?
|
Infant, Very Low Birth Weight | 2 | 2002 | 405 | 0.170 |
Why?
|
Anti-HIV Agents | 2 | 2013 | 4490 | 0.170 |
Why?
|
Humans | 52 | 2022 | 759255 | 0.170 |
Why?
|
Phylogeny | 1 | 2007 | 2765 | 0.170 |
Why?
|
Antitubercular Agents | 3 | 2016 | 1374 | 0.160 |
Why?
|
Infant, Premature, Diseases | 2 | 2002 | 708 | 0.160 |
Why?
|
Pandemics | 3 | 2020 | 8609 | 0.160 |
Why?
|
Evolution, Molecular | 1 | 2007 | 1883 | 0.160 |
Why?
|
Statistics as Topic | 1 | 2005 | 2364 | 0.160 |
Why?
|
Infant, Extremely Low Birth Weight | 2 | 2009 | 82 | 0.150 |
Why?
|
Algorithms | 6 | 2015 | 13946 | 0.150 |
Why?
|
New York | 2 | 2014 | 874 | 0.150 |
Why?
|
Likelihood Functions | 2 | 2013 | 988 | 0.140 |
Why?
|
Reproductive Techniques, Assisted | 1 | 2002 | 496 | 0.140 |
Why?
|
Models, Genetic | 1 | 2007 | 3443 | 0.140 |
Why?
|
Mass Screening | 1 | 2012 | 5419 | 0.140 |
Why?
|
Chronic Disease | 2 | 2011 | 9282 | 0.140 |
Why?
|
Echoencephalography | 3 | 2008 | 133 | 0.140 |
Why?
|
Infection Control | 2 | 2015 | 983 | 0.130 |
Why?
|
Environmental Exposure | 1 | 2011 | 4389 | 0.130 |
Why?
|
Morbidity | 1 | 2021 | 1764 | 0.130 |
Why?
|
Sensitivity and Specificity | 4 | 2015 | 14652 | 0.120 |
Why?
|
Ventilation | 1 | 2015 | 128 | 0.120 |
Why?
|
Geographic Information Systems | 2 | 2014 | 280 | 0.120 |
Why?
|
Rifampin | 1 | 2016 | 341 | 0.120 |
Why?
|
Prenatal Care | 1 | 2022 | 1126 | 0.120 |
Why?
|
Florida | 1 | 2015 | 427 | 0.120 |
Why?
|
Cerebral Palsy | 2 | 2009 | 471 | 0.110 |
Why?
|
Local Government | 1 | 2014 | 80 | 0.110 |
Why?
|
Disinfection | 1 | 2015 | 211 | 0.110 |
Why?
|
Child Health Services | 1 | 2018 | 644 | 0.110 |
Why?
|
Residence Characteristics | 2 | 2015 | 2035 | 0.110 |
Why?
|
Africa, Eastern | 1 | 2012 | 76 | 0.110 |
Why?
|
Measles Vaccine | 1 | 2013 | 81 | 0.100 |
Why?
|
Anthelmintics | 1 | 2012 | 82 | 0.100 |
Why?
|
United Nations | 1 | 2013 | 152 | 0.100 |
Why?
|
Regression Analysis | 2 | 2015 | 6359 | 0.100 |
Why?
|
Cerebral Hemorrhage | 2 | 2009 | 2659 | 0.100 |
Why?
|
Health Services Research | 1 | 2018 | 1809 | 0.090 |
Why?
|
Models, Theoretical | 2 | 2015 | 3556 | 0.090 |
Why?
|
Total Quality Management | 1 | 2012 | 264 | 0.090 |
Why?
|
South Africa | 2 | 2013 | 1820 | 0.090 |
Why?
|
Nigeria | 1 | 2014 | 762 | 0.090 |
Why?
|
Micronutrients | 1 | 2013 | 380 | 0.090 |
Why?
|
Uganda | 1 | 2015 | 1326 | 0.090 |
Why?
|
Mosquito Nets | 1 | 2010 | 9 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2015 | 1078 | 0.090 |
Why?
|
Chemoprevention | 1 | 2012 | 326 | 0.090 |
Why?
|
Culex | 1 | 2009 | 18 | 0.090 |
Why?
|
Cost Control | 1 | 2012 | 630 | 0.090 |
Why?
|
Costs and Cost Analysis | 1 | 2015 | 1676 | 0.090 |
Why?
|
Developmental Disabilities | 2 | 2009 | 1502 | 0.090 |
Why?
|
West Nile Fever | 1 | 2009 | 74 | 0.080 |
Why?
|
Masks | 1 | 2012 | 209 | 0.080 |
Why?
|
Anemia, Iron-Deficiency | 1 | 2013 | 368 | 0.080 |
Why?
|
Insect Vectors | 1 | 2009 | 134 | 0.080 |
Why?
|
Infant, Newborn | 8 | 2022 | 26109 | 0.080 |
Why?
|
Health Personnel | 1 | 2022 | 3309 | 0.080 |
Why?
|
Uncertainty | 1 | 2013 | 754 | 0.070 |
Why?
|
Incidence | 3 | 2015 | 21336 | 0.070 |
Why?
|
Urban Population | 1 | 2015 | 2015 | 0.070 |
Why?
|
Infant | 5 | 2018 | 35941 | 0.070 |
Why?
|
Child | 6 | 2018 | 79623 | 0.070 |
Why?
|
Child, Preschool | 6 | 2018 | 41935 | 0.070 |
Why?
|
Cleft Lip | 1 | 2012 | 504 | 0.070 |
Why?
|
Gastrointestinal Tract | 1 | 2013 | 830 | 0.070 |
Why?
|
Influenza A Virus, H5N1 Subtype | 1 | 2008 | 113 | 0.070 |
Why?
|
Folic Acid | 1 | 2013 | 1303 | 0.070 |
Why?
|
Software | 1 | 2021 | 4421 | 0.070 |
Why?
|
Cleft Palate | 1 | 2012 | 587 | 0.070 |
Why?
|
Demography | 3 | 2009 | 1648 | 0.070 |
Why?
|
Vaccination | 1 | 2018 | 3354 | 0.070 |
Why?
|
Iron | 1 | 2013 | 1785 | 0.060 |
Why?
|
Rural Population | 1 | 2015 | 2260 | 0.060 |
Why?
|
Birth Weight | 1 | 2013 | 2091 | 0.060 |
Why?
|
Predictive Value of Tests | 2 | 2013 | 15264 | 0.060 |
Why?
|
Sputum | 2 | 2016 | 502 | 0.060 |
Why?
|
Male | 12 | 2016 | 358719 | 0.060 |
Why?
|
Computer Systems | 1 | 2005 | 471 | 0.060 |
Why?
|
India | 1 | 2010 | 2343 | 0.060 |
Why?
|
Psychomotor Performance | 2 | 2009 | 1876 | 0.050 |
Why?
|
Female | 15 | 2022 | 390240 | 0.050 |
Why?
|
Confidentiality | 1 | 2007 | 610 | 0.050 |
Why?
|
Head | 1 | 2009 | 921 | 0.050 |
Why?
|
Weight Gain | 1 | 2013 | 2345 | 0.050 |
Why?
|
Selection Bias | 1 | 2004 | 358 | 0.050 |
Why?
|
Anti-Retroviral Agents | 1 | 2012 | 1780 | 0.050 |
Why?
|
Tuberculosis | 1 | 2015 | 2002 | 0.050 |
Why?
|
Bioterrorism | 1 | 2003 | 144 | 0.050 |
Why?
|
Triplets | 1 | 2002 | 43 | 0.050 |
Why?
|
Guinea Pigs | 2 | 2015 | 1314 | 0.050 |
Why?
|
ROC Curve | 1 | 2010 | 3570 | 0.050 |
Why?
|
Patient Admission | 1 | 2009 | 1383 | 0.050 |
Why?
|
Intensive Care Units, Neonatal | 1 | 2009 | 833 | 0.050 |
Why?
|
Decision Making | 1 | 2015 | 3920 | 0.050 |
Why?
|
Alleles | 1 | 2012 | 6897 | 0.050 |
Why?
|
Brain Damage, Chronic | 1 | 2002 | 267 | 0.050 |
Why?
|
Chorioamnionitis | 1 | 2002 | 156 | 0.050 |
Why?
|
Leukomalacia, Periventricular | 1 | 2002 | 184 | 0.040 |
Why?
|
Twins | 1 | 2002 | 339 | 0.040 |
Why?
|
Malaria | 1 | 2010 | 1225 | 0.040 |
Why?
|
Adult | 8 | 2016 | 219390 | 0.040 |
Why?
|
Computational Biology | 2 | 2013 | 3505 | 0.040 |
Why?
|
Neutrophil Infiltration | 1 | 2002 | 392 | 0.040 |
Why?
|
Public Health | 1 | 2013 | 2654 | 0.040 |
Why?
|
History, 20th Century | 1 | 2008 | 2777 | 0.040 |
Why?
|
Monte Carlo Method | 1 | 2005 | 1252 | 0.040 |
Why?
|
Gestational Age | 1 | 2008 | 3561 | 0.040 |
Why?
|
Animals | 6 | 2015 | 167838 | 0.040 |
Why?
|
Randomized Controlled Trials as Topic | 1 | 2016 | 10333 | 0.040 |
Why?
|
Brain Diseases | 1 | 2008 | 1540 | 0.040 |
Why?
|
Cross-Sectional Studies | 2 | 2022 | 25860 | 0.040 |
Why?
|
Adolescent | 4 | 2015 | 87560 | 0.040 |
Why?
|
Madagascar | 1 | 2018 | 110 | 0.040 |
Why?
|
DNA Mutational Analysis | 1 | 2007 | 4111 | 0.040 |
Why?
|
Microbial Sensitivity Tests | 2 | 2016 | 1943 | 0.040 |
Why?
|
Treatment Outcome | 3 | 2021 | 64879 | 0.040 |
Why?
|
Respiratory Tract Infections | 1 | 2005 | 1001 | 0.040 |
Why?
|
Child Development | 1 | 2008 | 2275 | 0.030 |
Why?
|
Massachusetts | 1 | 2009 | 8788 | 0.030 |
Why?
|
Fetal Diseases | 1 | 2002 | 910 | 0.030 |
Why?
|
Sequence Analysis, DNA | 1 | 2007 | 4716 | 0.030 |
Why?
|
Immunization Programs | 1 | 2018 | 268 | 0.030 |
Why?
|
Hypotension | 1 | 2002 | 882 | 0.030 |
Why?
|
Placenta | 2 | 2002 | 1699 | 0.030 |
Why?
|
Genetic Variation | 2 | 2009 | 6531 | 0.030 |
Why?
|
Neurologic Examination | 2 | 2009 | 916 | 0.030 |
Why?
|
Tuberculin Test | 1 | 2015 | 206 | 0.030 |
Why?
|
Uzbekistan | 1 | 2013 | 1 | 0.030 |
Why?
|
Bread | 1 | 2013 | 23 | 0.030 |
Why?
|
Flour | 1 | 2013 | 20 | 0.030 |
Why?
|
Clinical Trials, Phase II as Topic | 1 | 2016 | 629 | 0.030 |
Why?
|
Mycobacterium tuberculosis | 2 | 2016 | 1905 | 0.030 |
Why?
|
Pregnancy | 4 | 2022 | 29658 | 0.030 |
Why?
|
Folic Acid Deficiency | 1 | 2013 | 115 | 0.030 |
Why?
|
Organization and Administration | 1 | 2012 | 54 | 0.030 |
Why?
|
Food, Fortified | 1 | 2013 | 188 | 0.030 |
Why?
|
Stomach Neoplasms | 1 | 2002 | 1422 | 0.030 |
Why?
|
Lung Diseases | 1 | 2002 | 1915 | 0.020 |
Why?
|
Surgical Procedures, Operative | 1 | 2003 | 1914 | 0.020 |
Why?
|
Models, Biological | 1 | 2007 | 9466 | 0.020 |
Why?
|
Multicenter Studies as Topic | 1 | 2016 | 1719 | 0.020 |
Why?
|
Malawi | 1 | 2012 | 301 | 0.020 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2012 | 363 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2002 | 2901 | 0.020 |
Why?
|
Critical Care | 1 | 2003 | 2697 | 0.020 |
Why?
|
Retreatment | 1 | 2012 | 600 | 0.020 |
Why?
|
Treatment Failure | 1 | 2016 | 2642 | 0.020 |
Why?
|
Mozambique | 1 | 2010 | 55 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2003 | 3731 | 0.020 |
Why?
|
Neutrophils | 1 | 2002 | 3767 | 0.020 |
Why?
|
Insecticide-Treated Bednets | 1 | 2010 | 68 | 0.020 |
Why?
|
Middle Aged | 5 | 2016 | 219653 | 0.020 |
Why?
|
Private Sector | 1 | 2012 | 398 | 0.020 |
Why?
|
Infectious Disease Transmission, Patient-to-Professional | 1 | 2012 | 250 | 0.020 |
Why?
|
Risk Factors | 2 | 2014 | 74167 | 0.020 |
Why?
|
Peru | 1 | 2012 | 867 | 0.020 |
Why?
|
Young Adult | 1 | 2015 | 58483 | 0.020 |
Why?
|
CD-ROM | 1 | 2008 | 24 | 0.020 |
Why?
|
Certification | 1 | 2012 | 423 | 0.020 |
Why?
|
Administration, Oral | 1 | 2016 | 4046 | 0.020 |
Why?
|
Mutation | 1 | 2013 | 29877 | 0.020 |
Why?
|
Hemiplegia | 1 | 2008 | 136 | 0.020 |
Why?
|
Hemoglobins | 1 | 2013 | 1516 | 0.020 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2012 | 585 | 0.020 |
Why?
|
Microsatellite Repeats | 1 | 2009 | 787 | 0.020 |
Why?
|
Logistic Models | 1 | 2002 | 13309 | 0.020 |
Why?
|
Risk Assessment | 2 | 2014 | 24049 | 0.020 |
Why?
|
United States | 3 | 2009 | 72237 | 0.020 |
Why?
|
Feces | 1 | 2013 | 1462 | 0.020 |
Why?
|
Quadriplegia | 1 | 2008 | 226 | 0.020 |
Why?
|
Cohort Studies | 3 | 2016 | 41247 | 0.020 |
Why?
|
Benchmarking | 1 | 2012 | 1040 | 0.020 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6532 | 0.020 |
Why?
|
Health Services Accessibility | 1 | 2003 | 5377 | 0.020 |
Why?
|
Gene Frequency | 1 | 2012 | 3603 | 0.020 |
Why?
|
Risk | 1 | 2016 | 9623 | 0.010 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2016 | 10827 | 0.010 |
Why?
|
Microcephaly | 1 | 2008 | 422 | 0.010 |
Why?
|
Canada | 1 | 2009 | 2124 | 0.010 |
Why?
|
Geography | 1 | 2005 | 661 | 0.010 |
Why?
|
Confidence Intervals | 1 | 2009 | 2932 | 0.010 |
Why?
|
Public Health Administration | 1 | 2005 | 243 | 0.010 |
Why?
|
Cost of Illness | 1 | 2012 | 1936 | 0.010 |
Why?
|
Ureaplasma | 1 | 2002 | 60 | 0.010 |
Why?
|
Reproducibility of Results | 2 | 2012 | 20031 | 0.010 |
Why?
|
Infant, Premature | 2 | 2002 | 2087 | 0.010 |
Why?
|
Bacteria | 1 | 2013 | 2188 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2016 | 12522 | 0.010 |
Why?
|
Medical History Taking | 1 | 2005 | 773 | 0.010 |
Why?
|
Brain | 2 | 2012 | 26863 | 0.010 |
Why?
|
Patient Care Team | 1 | 2012 | 2510 | 0.010 |
Why?
|
Respiration, Artificial | 2 | 2002 | 2616 | 0.010 |
Why?
|
Italy | 1 | 2002 | 840 | 0.010 |
Why?
|
Calibration | 1 | 2003 | 816 | 0.010 |
Why?
|
Appointments and Schedules | 1 | 2003 | 437 | 0.010 |
Why?
|
Motor Activity | 1 | 2009 | 2687 | 0.010 |
Why?
|
Multivariate Analysis | 2 | 2002 | 12152 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12940 | 0.010 |
Why?
|
Gastrectomy | 1 | 2002 | 668 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 2002 | 976 | 0.010 |
Why?
|
Registries | 1 | 2012 | 8434 | 0.010 |
Why?
|
DNA | 1 | 2009 | 7237 | 0.010 |
Why?
|
Ultrasonography | 1 | 2009 | 5955 | 0.010 |
Why?
|
Health Services Needs and Demand | 1 | 2003 | 1396 | 0.010 |
Why?
|
Lymphatic Metastasis | 1 | 2002 | 2943 | 0.010 |
Why?
|
Ambulatory Care | 1 | 2005 | 2775 | 0.010 |
Why?
|
Follow-Up Studies | 2 | 2008 | 39216 | 0.010 |
Why?
|
Hospitals, Pediatric | 1 | 2003 | 1841 | 0.010 |
Why?
|
Inflammation | 1 | 2013 | 10747 | 0.010 |
Why?
|
Comorbidity | 1 | 2008 | 10547 | 0.010 |
Why?
|
Genome-Wide Association Study | 1 | 2012 | 12580 | 0.010 |
Why?
|
Prospective Studies | 2 | 2012 | 54204 | 0.010 |
Why?
|
Diagnosis, Differential | 1 | 2008 | 12964 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2003 | 1927 | 0.010 |
Why?
|
Retrospective Studies | 2 | 2012 | 80121 | 0.010 |
Why?
|
Cognition | 1 | 2008 | 6940 | 0.010 |
Why?
|
Time Factors | 1 | 2012 | 40109 | 0.010 |
Why?
|
Boston | 1 | 2003 | 9274 | 0.010 |
Why?
|
Survival Analysis | 1 | 2002 | 10185 | 0.010 |
Why?
|
Sex Factors | 1 | 2002 | 10518 | 0.000 |
Why?
|
Survival Rate | 1 | 2002 | 12800 | 0.000 |
Why?
|
Pregnancy Complications | 1 | 2002 | 2940 | 0.000 |
Why?
|
Sepsis | 1 | 2002 | 2594 | 0.000 |
Why?
|
Emergency Service, Hospital | 1 | 2005 | 7788 | 0.000 |
Why?
|
Age Factors | 1 | 2002 | 18394 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2002 | 21988 | 0.000 |
Why?
|
Prognosis | 1 | 2002 | 29561 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2009 | 36160 | 0.000 |
Why?
|
Aged, 80 and over | 1 | 2002 | 58867 | 0.000 |
Why?
|
Aged | 1 | 2002 | 168617 | 0.000 |
Why?
|